Protein kinase C activators decrease dopamine uptake into striatal synaptosomes

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1527-1532

  Copeland, B J ^a   Vogelsberg, V ^a   Neff, N H ^a   Hadjiconstantinou, M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4ALPHA PHORBOL; 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BENZATROPINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DESIPRAMINE; DIOCTANOIN; DOPAMINE; DOPAMINE TRANSPORTER; DRUG VEHICLE; FLUOXETINE; LACTATE DEHYDROGENASE; MAZINDOL; OKADAIC ACID; PARGYLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE INHIBITOR; RESERPINE; STAUROSPORINE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; EMBRYO; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESENCEPHALON; MICHAELIS CONSTANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER;

ANIMALS; CORPUS STRIATUM; DIGLYCERIDES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MALE; MICE; MICE, INBRED STRAINS; PROTEIN KINASE C; SYNAPTOSOMES; TETRADECANOYLPHORBOL ACETATE;

EID: 0030433198     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ANDERSON, G. M. AND HORNE, W. C.: Activators of protein kinase C decrease serotonin transport in human platelets. Biochim. Biophys. Acta 1137: 331-337, 1992.
2. ANNUNZIATO, L., LABLANC, P., KORDON, C. AND WEINER, R. I.: Differences in the kinetics of dopamine uptake in synaptosome preparations in the median eminence relative to other dopaminergic innervated brain regions. Neuroendocrinology 31: 316-320, 1980.
3. ANNUNZIATO, L. AND WEINER, R. I.: Characteristics of dopamine uptake and 3,4-dihydroxyphenylacetic acid formation in the dopaminergic terminals of the neurointermediate lobe of the pituitary gland. Neuroendocrinology 31: 8-12, 1980.
4. BERTORELLO, A. M., HOPFIELD, J. F., APERIA, A. AND GBEENGARD, P.: Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature (Lond.) 347: 386-388, 1990.
5. CASADO, M., BENDAHAN, A., ZAFRA, F., DANBOLT, N. C., AARGON, C., GIMENEZ, C. AND KANNER, B. I.: Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J. Biol. Chem. 268: 27313-27317, 1993.
6. CASADO, M., ZAFRA, F., ARAGON, C. AND GIMENEZ, C.: Activation of high-affinity uptake of glutamate by phorbol esters in primary glial cell cultures. J. Neurochem. 57: 1185-1190, 1991.
7. CASS, W. A. AND GERHARDT, G. A.: Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176: 259-263, 1994.
8. 2+. J. Neurochem. 52: 1905-1912, 1989.
9. COREY, J. L., DAVIDSON, N., LESTER, H. A., BRECHA, N. AND QUICK, M. W.: Protein kinase C modulates the activity of a cloned gamma-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J. Biol. Chem. 269: 14759-14767, 1994.
10. +. J. Neurosci. 13: 3104-3111, 1993.
11. DAVIS, M. E. AND PATRICK, R. L.: Diacylglycerol-induced stimulation of neurotransmitter release from rat brain striatal synaptosomes. J. Neurochem. 54: 662-668, 1990.
12. ESHLEMAN, A. J., HENNINGSEN, R. A., NEVE, K. A. AND JANOWSKY, A.: Release of dopamine via the human transporter. Mol. Pharmacol. 45: 312-316, 1994.
13. FISCHER, J. F. AND CHO, A. K.: Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208: 203-209, 1979.
14. GIROS, B. AND CARON, M. G.: Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14: 43-49, 1993.
15. GIROS, B., EL MESTIKAWY, S., BERTRAND, L. AND CARON, M. G.: Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295: 149-154, 1991.
16. GIROS, B., EL MESTIKAWY, S., GODINOT, N., ZHENG, K, HAN, H., YANG-FENG, T. AND CARON, M. G.: Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42: 383-390, 1992.
17. GOMEZ, J., CASADO, M., GIMENEZ, C. AND ARAGON, C.: Inhibition of high-affinity gamma-aminobutyric acid uptake in primary astrocyte cultures by phorbol esters and phospholipase C. Biochem. J. 275: 435-439, 1991.
18. GRAY, E. G. AND WHITTAKER, V. P.: The isolation of nerve endings from brain: An electron microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96: 79-88, 1962.
19. HADJICONSTANTINOU, M. AND NEFF, N. H.: Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 51: 1190-1196, 1988.
20. 3H]dopamine into synaptosomes from rat striatum. Mol. Pharmacol. 10: 746-758, 1974.
21. HORN, A. S.: Dopamine uptake: A review of progress in the last decade. Prog Neurobiol. 34: 387-400, 1990.
22. IVERSEN, L. L.: Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 41: 571-591, 1971.
23. 3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res. 531: 338-341, 1990.
24. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 26: 35-44, 1984.
25. JAVITCH, J. A., D'AMATO, R. J., STRITTMATTER, S. M. AND SNYDER, S. H.: Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U.S.A. 82: 2173-2177, 1985.
26. +)-ATPase activity: Head-group specificity and fatty acid fluidity. Biochim. Biophys. Acta 282: 277-292, 1972.
27. KITAYAMA, S., DOHI, T. AND UHL, G. R.: Phorbol esters alter functions of the expressed dopamine transporter. Eur. J. Pharmacol. 268: 115-119, 1994.
28. 3H]glutamate by striatal synaptosomes. J. Neurochem. 63: 2108-2117, 1994.
29. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
30. MCDONOUGH, A. A. AND FARLEY, R. A.: Regulation of Na,K-ATPase activity. Cur. Opin. Nephrol. Hyperten. 2: 725-734, 1993.
31. MEIERGERD, S. M., HOOKS, S. M. AND SCHENK, J. O.: The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration. J. Neurochem. 63: 1277-1281, 1994.
32. MEIERGERD, S. M., PATTERSON, T. A. AND SCHENK, J. O.: D2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61: 764-767, 1993.
33. MELAMED, E., ROSENTHAL, J., COHEN, O., GLOBUS AND UZZAN, A.: Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neu-rotoxicity of MPTP. Eur. J. Pharmacol. 116: 179-181, 1985.
34. NG, J. P., HUBERT, G. W. AND JUSTICE, J. B., JR.: Increased stimulated release and uptake of dopamine in nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry. J. Neurochem. 56: 1485-1492, 1991.
35. ONALI, P. AND OLIANAS, M. C.: Stimulation of dopamine synthesis and activation of tyrosine hydroxylase by phorbol diesters in rat striatum. Life Sci. 40: 1219-1228, 1987.
36. OSAWA, I., SAITO, N., KOGA, T. AND TANAKA, C.: Phorbol ester-induced inhibition of GABA uptake by synaptosomes and by Xenopus oocytes expressing GABA transporter (GAT1). Neurosci. Res. 19: 287-293, 1994.
37. 3H]-dopamine uptake. Br. Res. 641: 83-91, 1994.
38. RAITERI, M., CERRITO, F., CERVONI, A. M. AND LEVI, G.: Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208: 195-202, 1979.
39. RITZ, M. C., LAMB, R. J., GOLDBERG, S. R. AND KUHAR, M. J.: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash. DC) 237: 1219-1223, 1987.
40. SATO, K., ADAMS, R., BETZ, H. AND SCHLOSS, P.: Modulation of recombinant glycine transporter (GLYT1b) by activation of protein kinase C. J. Neurochem. 65: 1967-1973, 1995.
41. SCHOMIG, E., MICHAEL-HEPP, J. AND SCHONFELD, C. L.: Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 495-501, 1989.
42. 3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203: 141-144, 1991.
43. TANAKA, C. AND NISHIZUKA, Y.: The protein kinase C family for neuronal signaling. Ann. Rev. Neurosci. 17: 551-567, 1994.
44. TIAN, Y., KAPATOS, G., GRANNEMAN, J. G. AND BANNON, M. J.: Dopamine and gamma-aminobutyric acid transporters: Differential regulation by agents that promote phosphorylation. Neurosci. Lett. 173: 143-146, 1994.
45. USDIN, T. B., MEZEY, E., CHEN, C., BROWNSTEIN, M. J. AND HOFFMAN, B. J.: Cloning of the cocaine-sensitive bovine dopamine transporter. Proc, Nat. Acad. Sci. U.S.A. 88: 11168-11171, 1991.
46. WIGHTMAN, R. M. AND ZIMMERMAN, J. B.: Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Rev. 15: 135-144, 1990.
47. WORLEY, P. F., BARABAN, J. M. AND SNYDER, S. H.: Heterogeneous localization of protein kinase C in rat brain: Autoradiographic analysis of phorbol ester receptor binding. J. Neurosci. 6: 199-207, 1986.
48. WROBLESKI, R. AND LADUE, J. S.: Lactic acid dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90: 210-215, 1955.
49. XIA, Y., GOEBEL, D. J., KAPATOS, G. AND BANNON, M. J.: Quantitation of rat dopamine transporter mRNA: Effects of cocaine treatment and withdrawal. J. Neurochem. 59: 1179-1182, 1992.
50. 3H]-dopamine. Neuropharmacology 29: 475-486, 1990.
51. YOUNG, E. A., NEFF, N. H. AND HADJICONSTANTINOU, M.: Phorbol ester administration transiently increases aromatic L-amino acid decarboxylase activity of the mouse striatum and midbrain. J. Neurochem. 63: 694-697, 1994.